openPR Logo
Press release

North America Gastric Bands and Balloons Market Projected to Grow at 7.5% CAGR

09-24-2025 01:16 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

North America Gastric Bands and Balloons Market

North America Gastric Bands and Balloons Market

Introduction
Obesity has become a critical public health challenge in North America, with rising prevalence rates leading to increased risks of diabetes, cardiovascular disease, and other chronic conditions. As healthcare systems focus on preventive care and weight management, demand for bariatric interventions has surged. Among the available options, gastric bands and balloons have gained popularity as effective, minimally invasive treatments for obesity.

These devices provide an alternative to traditional bariatric surgery by reducing stomach capacity and controlling food intake, offering patients a safe and reversible option. With growing awareness, technological advancements, and supportive reimbursement policies in the United States and Canada, the North America Gastric Bands and Balloons Market is positioned for robust growth in the next decade.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72320

Market Overview
According to Exactitude Consultancy, the North America Gastric Bands and Balloons Market was valued at USD 450 million in 2024 and is projected to reach USD 930 million by 2034, growing at a CAGR of 7.5% during the forecast period.

Key Highlights
• Obesity prevalence in the U.S. exceeds 40% of the adult population, fueling demand for gastric bands and balloons.
• Gastric balloons dominate the market due to higher patient acceptance, minimally invasive insertion, and temporary use.
• Favorable reimbursement coverage in the U.S. and increasing healthcare spending in Canada boost market adoption.
• Market growth is supported by lifestyle-related health conditions and rising preference for outpatient weight-loss procedures.
• However, device-related complications and patient adherence challenges pose barriers.

Leading Players include Allurion Technologies, Apollo Endosurgery, Medtronic, Ethicon (Johnson & Johnson), ReShape Lifesciences, Obalon Therapeutics, and Spatz Medical.

Segmentation Analysis
By Product
• Gastric Bands
• Gastric Balloons (Single Balloon, Dual Balloon, Adjustable Balloon Systems)

By Platform
• Hospitals
• Ambulatory Surgical Centers
• Specialty Weight-Loss Clinics

By Technology
• Endoscopic Intragastric Balloon Systems
• Laparoscopic Adjustable Gastric Band Systems
• Non-Invasive Balloon Technologies

By End-Use
• Public Healthcare Providers
• Private Healthcare Networks
• Medical Tourism Facilities

By Application
• Obesity Management
• Type 2 Diabetes Management
• Metabolic Syndrome & Other Conditions

Segmentation Summary
Gastric balloons represent the largest and fastest-growing product category due to their minimally invasive nature and rising patient preference. Adjustable gastric bands are still in use but face declining adoption because of long-term complications. Hospitals remain the primary platform, but ambulatory surgical centers and weight-loss clinics are rapidly gaining traction as cost-effective, convenient options.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/72320/north-america-gastric-bands-and-balloons-market

Regional Analysis
United States
• Largest share of the North American market.
• High obesity rates, supportive reimbursement policies, and well-developed bariatric surgery infrastructure.
• Strong adoption of gastric balloons for outpatient procedures.
Canada
• Rising obesity prevalence and growing healthcare expenditure drive adoption.
• Private clinics are expanding weight-loss treatment offerings.
• Increasing demand for minimally invasive and reversible interventions.
Mexico
• Medical tourism hotspot for bariatric procedures due to cost advantages.
• Growing middle-class population and lifestyle changes are contributing to obesity prevalence.
• Expanding private hospital networks are investing in bariatric care facilities.

Regional Summary
The U.S. dominates in terms of market value, but Canada is showing steady growth with expanding private care networks. Mexico offers significant opportunities, particularly through medical tourism, where international patients seek affordable bariatric interventions.

Market Dynamics
Growth Drivers
1. Rising obesity prevalence - Lifestyle changes and dietary habits have fueled obesity across North America.
2. Minimally invasive preference - Gastric balloons and bands offer reversible, less invasive alternatives to bariatric surgery.
3. Reimbursement support - Coverage in the U.S. makes these procedures accessible to a broader patient base.
4. Technological advancements - Development of adjustable and swallowable gastric balloons enhances adoption.

Challenges
• Device-related complications, including balloon deflation and band erosion.
• Declining popularity of gastric bands due to long-term failure rates.
• Patient compliance issues with diet and follow-up care.

Latest Trends
• Growth of swallowable, non-invasive balloons that require no endoscopic placement.
• Expansion of medical tourism in Mexico for cost-effective bariatric solutions.
• Integration of digital health monitoring tools to track patient outcomes post-procedure.
• Increasing focus on comorbidity management (diabetes, hypertension) through bariatric devices.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72320

Competitor Analysis
Key Players
• Allurion Technologies
• Apollo Endosurgery
• Medtronic plc
• Ethicon (Johnson & Johnson)
• ReShape Lifesciences
• Obalon Therapeutics
• Spatz Medical
• Cousin Biotech

Competitive Landscape Summary
Apollo Endosurgery and Allurion Technologies dominate the gastric balloon segment with innovative devices such as swallowable and adjustable balloons. Ethicon and Medtronic remain significant players in gastric bands, though demand is declining. ReShape Lifesciences and Obalon focus on advanced balloon technologies targeting outpatient settings. Competitive strategies include mergers, new product launches, and expansion into Mexico's medical tourism market.

Conclusion
The North America Gastric Bands and Balloons Market is projected to grow from USD 450 million in 2024 to USD 930 million by 2034, at a CAGR of 7.5%. Rising obesity prevalence, technological innovation, and supportive reimbursement frameworks will continue to drive adoption across the region.

Key Takeaways
• Gastric balloons dominate, with adjustable and swallowable systems gaining popularity.
• U.S. leads the market, Canada shows strong growth, and Mexico benefits from medical tourism.
• Technological advances and outpatient treatment trends will shape the future of this market.
• Competitive differentiation will hinge on safety, convenience, and affordability.

This report is also available in the following languages : Japanese (北米の胃バンドおよびバルーン市場), Korean (북미 위밴드 및 풍선 시장), Chinese (北美胃束带和胃球囊市场), French (Marché nord-américain des anneaux et ballons gastriques), German (Nordamerikanischer Markt für Magenbänder und Ballons), and Italian (Mercato dei nastri e dei palloncini gastrici del Nord America), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72320

Our More Reports:

Ptosis Market
https://exactitudeconsultancy.com/reports/72276/ptosis-market

Polypoidal Choroidal Vasculopathy (PCV) Market
https://exactitudeconsultancy.com/reports/72274/polypoidal-choroidal-vasculopathy-pcv-market

Pars Planitis Market
https://exactitudeconsultancy.com/reports/72272/pars-planitis-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America Gastric Bands and Balloons Market Projected to Grow at 7.5% CAGR here

News-ID: 4195915 • Views:

More Releases from Exactitude Consultancy

North America ERCP and PTC Devices Market Expected to Grow at 8.1% CAGR
North America ERCP and PTC Devices Market Expected to Grow at 8.1% CAGR
Introduction Biliary and pancreatic disorders such as gallstones, strictures, bile duct cancers, and pancreatitis represent significant healthcare challenges in North America. Diagnostic and therapeutic interventions like Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) have become indispensable in managing these conditions. Both procedures require advanced devices - including endoscopes, catheters, guidewires, stents, and balloon dilators - designed for precision and minimally invasive treatment. Rising prevalence of gastrointestinal (GI) cancers, an aging
Uveitis Market Forecasted to Reach USD 4.1 Billion by 2034
Uveitis Market Forecasted to Reach USD 4.1 Billion by 2034
Uveitis is an inflammatory eye disease that affects the uvea, the middle layer of the eye. It can lead to symptoms such as pain, redness, blurred vision, and sensitivity to light, and can result in retinal damage, cataracts, glaucoma, and permanent vision loss if left untreated. Uveitis can be caused by a variety of factors, including autoimmune diseases (e.g., rheumatoid arthritis, sarcoidosis), infections, and trauma, and may affect either one
Glaucoma Market Forecasted to Reach USD 6.9 Billion by 2034
Glaucoma Market Forecasted to Reach USD 6.9 Billion by 2034
Glaucoma is a group of eye diseases characterized by optic nerve damage, often due to increased intraocular pressure (IOP). It is a leading cause of irreversible blindness, particularly among elderly populations. The two most common types are primary open-angle glaucoma (POAG) and angle-closure glaucoma, with POAG accounting for over 70% of glaucoma cases. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72297 With the growing burden of aging populations, rising prevalence
Retinitis Pigmentosa Market Forecasted to Reach USD 4.5 Billion by 2034
Retinitis Pigmentosa Market Forecasted to Reach USD 4.5 Billion by 2034
Retinitis pigmentosa (RP) is a genetically heterogeneous group of inherited retinal diseases that cause progressive degeneration of the retina, primarily affecting the photoreceptor cells. It leads to progressive vision loss, starting with night blindness and peripheral vision loss and eventually advancing to central vision loss. RP is a leading cause of blindness in young adults, with a global prevalence of 1 in 4,000 individuals. Download Full PDF Sample Copy of Market

All 5 Releases


More Releases for Gastric

Rising Gastric Cancer Cases Fuel Growth In Gastric Cancer Drugs Market Driving M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Gastric Cancer Drugs Market Size By 2025? In recent times, the market size for gastric cancer drugs has seen a swift expansion. Projections forecast growth from $4.41 billion in 2024 to $4.9 billion in 2025, a compound annual growth rate (CAGR) of 11.2%. Factors contributing
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Gastric Ulcers Market Size By 2025? In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leadi …
How Are the key drivers contributing to the expansion of the gastric ulcers market? The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance,
Top Factor Driving Gastric Cancer Drugs Market Growth in 2025: Rising Gastric Ca …
What market dynamics are playing a key role in accelerating the growth of the gastric cancer drugs market? The rise in obesity and smoking rates has led to an increased prevalence of gastric cancer. Factors like tobacco use and poor dietary habits have been linked to a higher risk of developing this disease. As per data from the Government Digital Service in the UK, it was projected in May 2023 that
Gastric Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Gastric Cancer
Gastric Function Test Market - Empowering Digestive Health: Gastric Function Tes …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Gastric Function Test Market. Gastric Function Test Market: https://www.growthplusreports.com/report/gastric-function-test-market/9126 The Gastric Function Test Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the